XML 26 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2020
Summary of Significant Accounting Policies  
Schedule of stock-based compensation expense

During the three months ended March 31, 2020 and 2019, the Company recorded stock-based compensation expense, which was allocated as follows in the condensed consolidated statements of operations (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

    

2020

    

2019

Research and development

 

$

165

 

$

135

General and administrative

 

 

174

 

 

273

Total

 

$

339

 

$

408

 

Schedule of anti-dilutive common stock equivalents excluded from calculation of diluted net loss per share

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

    

2020

    

2019

Stock options

 

1,206,644

 

758,304

Common stock warrants

 

6,193,749

 

6,201,949

 

 

7,400,393

 

6,960,253

 

Schedule of reconciliation of cash, cash equivalents and restricted cash

 

 

 

 

 

 

 

 

 

 

March 31, 

 

    

2020

    

2019

Cash and cash equivalents

 

$

13,344

 

$

11,652

Restricted cash (1)

 

 

235

 

 

113

Total

 

$

13,579

 

$

11,765


(1)

Included in prepaid expenses and other current assets and other assets as of March 31, 2020.